This refers to the total cumulative number of doses of any vaccine product distributed by manufacturers to EU/EEA countries.
This refers to the total number of vaccine doses distributed by manufacturers to EU/EEA countries divided by the size of the total population in each country. Population denominators for the total population are obtained from Eurostat/UN.
This refers to the total number of doses of any vaccine product administered in EU/EEA countries.
This refers to the cumulative uptake of a complete primary course with any vaccine product and is presented for the total population, adults (18+), people aged 60 years and above (60+) and children below 18 years. It is calculated as follows: number of complete primary courses administered divided by the size of the population. The uptake is expressed as percentage (%). Primary course is defined according to the authorised schedule for each vaccine product at EU level. Population denominators are obtained from Eurostat/UN.
This refers to the cumulative uptake of the first booster dose and is presented for the total population, adults (18+) and people aged 60 years and above (60+). See definition of first booster below. It is calculated as follows: number of first booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN.
First booster: for surveillance purpose, this refers to the first additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both first booster doses administered to immunocompetent persons and additional primary course doses administered to immunocompromised individuals.
This refers to the cumulative uptake of the second booster dose and is presented for the total population, adults (18+) and people aged 60 years and above (60+). See definition of second booster below. It is calculated as follows: number of second booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN.
Second booster: for surveillance purpose, this refers to the second additional dose of COVID-19 vaccine administered after the standard primary course. Therefore, the count and uptake estimates may include both second booster doses administered to immunocompetent persons and second additional doses administered to immunocompromised individuals after a standard primary course.
This refers to the cumulative uptake of the third booster dose and is presented for the total population, adults (18+) and people aged 60 years and above (60+). See definition of third booster below. It is calculated as follows: number of third booster doses cumulatively administered divided by the size of the population. The uptake is expressed as percentage (%). Population denominators are obtained from Eurostat/UN.
Third booster: for surveillance purpose, this refers to third additional doses of COVID-19 vaccines administered after the standard primary course. Therefore, the count and uptake estimates may include both third booster doses administered to immunocompetent persons and third additional doses administered to immunocompromised individuals after a standard primary course.
Discrepancies with figures from national reports may be explained by different data reporting pace and timing of the data presented in the Vaccine Tracker. Please, refer to Notes on the data tab for additional information on data reporting and data interpretation.
Please refer to the Notes on the data tab to export the full data set.